Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance

NF-κB is constitutively activated in many cancer types and is a potential key mediator of tumor-associated inflammation, tumor growth, and metastasis. We investigated the role of cancer cell NF-κB activity in T cell-mediated antitumor responses. In tumors rendered immunogenic by model antigen expres...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 123; no. 6; pp. 2509 - 2522
Main Authors Hopewell, Emily L, Zhao, Weipeng, Fulp, William J, Bronk, Crystina C, Lopez, Alexis S, Massengill, Michael, Antonia, Scott, Celis, Esteban, Haura, Eric B, Enkemann, Steven A, Chen, Dung-Tsa, Beg, Amer A
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.06.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:NF-κB is constitutively activated in many cancer types and is a potential key mediator of tumor-associated inflammation, tumor growth, and metastasis. We investigated the role of cancer cell NF-κB activity in T cell-mediated antitumor responses. In tumors rendered immunogenic by model antigen expression or following administration of antitumor vaccines, we found that high NF-κB activity leads to tumor rejection and/or growth suppression in mice. Using a global RNA expression microarray, we demonstrated that NF-κB enhanced expression of several T cell chemokines, including Ccl2, and decreased CCL2 expression was associated with enhanced tumor growth in a mouse lung cancer model. To investigate NF-κB function in human lung tumors, we identified a gene expression signature in human lung adenocarcinoma cell lines that was associated with NF-κB activity level. In patient tumor samples, overall lung tumor NF-κB activity was strongly associated with T cell infiltration but not with cancer cell proliferation. These results therefore indicate that NF-κB activity mediates immune surveillance and promotes antitumor T cell responses in both murine and human lung cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Authorship note: Emily L. Hopewell and Weipeng Zhao contributed equally to this work.
ISSN:0021-9738
1558-8238
DOI:10.1172/JCI67250